17 results
8-K
EX-10.1
ADPT
Adaptive Biotechnologies Corp
12 Sep 22
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
8:45am
with this Agreement.
Section 3.24.Data Privacy and Information Security.
(a)The Company and its Subsidiaries maintain industry appropriate data security policies … to privacy or data security, and, to the Knowledge of the Company, none of the Company or any Subsidiary nor any Product Assets have experienced
10-K
2019 FY
ADPT
Adaptive Biotechnologies Corp
26 Feb 20
Annual report
4:53pm
in violation of the FTCA. The FTC expects a company’s data security measures to be reasonable and appropriate in light of the sensitivity and volume … or practices in or affecting commerce in violation of Section 5(a) of the FTCA. The FTC expects a company’s data security measures to be reasonable
424B4
cr3pi 44hfjui
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
bam0lr np5xs4
9 Jan 20
Draft registration statement
12:00am
424B4
u7jcd8pgdi0
27 Jun 19
Prospectus supplement with pricing info
5:24pm
S-1
162h5
30 May 19
IPO registration
5:20pm
S-1
EX-10.2
qkfmtaff5u ptakl
30 May 19
IPO registration
5:20pm
DRS/A
n23vb36wxp3 4n
8 May 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.2
fc1gh28
8 May 19
Draft registration statement (amended)
12:00am
DRS
q3is4ypiupbjx2ka82i8
29 Mar 19
Draft registration statement
12:00am
- Prev
- 1
- Next